News

Google News
european-biotechnology. com

Funding: HMNC and the Long Road to Precision Psychiatry - European Biotechnology Magazine

8+ hour, 13+ min ago  (607+ words) With a first $50 million tranche of its Series B financing and a commercial partnership with MEDICE, HMNC Brain Health has secured fresh capital for its depression programmes. The deal marks an important milestone for the Munich-based company " nearly a decade…...

Symbols: nasdaq:envb,nasdaq:cgtx